Margetuximab
Product Specifications
CAS Number
1350624-75-7
Target
HER, EGFR
Related Pathways
JAK/STAT signaling, Tyrosine Kinase/Adaptors, Angiogenesis
Purity
0.993
Bioactivity
Margetuximab (MGAH-22) is a second generation anti-human epidermal growth factor receptor 2 protein (HER2) monoclonal antibody with anti-tumor activity for the study of metastatic HER2-positive breast cancer and for the synthesis of nanomedicines.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2140029-01 0.01 mg
Recombinant Cluster Of Differentiation 99 (CD99)
Sign In for Pricing
View Details MBS2140029-02 0.05 mg
Recombinant Cluster Of Differentiation 99 (CD99)
Sign In for Pricing
View Details MBS2140029-03 0.1 mg
Recombinant Cluster Of Differentiation 99 (CD99)
Sign In for Pricing
View Details MBS2140029-04 0.2 mg
Recombinant Cluster Of Differentiation 99 (CD99)
Sign In for Pricing
View Details MBS2140029-05 0.5 mg
Recombinant Cluster Of Differentiation 99 (CD99)
Sign In for Pricing
View Details MBS2140029-06 1 mg
Recombinant Cluster Of Differentiation 99 (CD99)
Sign In for Pricing
View Details